Levomilnacipran Completed Phase 1 Trials for Subject Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02266966Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging